Sionna Therapeutics (SION) Profit After Tax (2024 - 2026)
Sionna Therapeutics (SION) reported Profit After Tax of -$624000.0 for Q1 2026, up 96.21% on a YoY basis from -$318020.0 in Q1 2025, and up 96.92% sequentially from -$20.3 million in Q4 2025.
Sionna Therapeutics (SION) Profit After Tax (2024 - 2026) Analysis & Trends
Sionna Therapeutics (SION) has 3 years of Profit After Tax data on file, last reported at -$624000.0 in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 96.21% year-over-year to -$624000.0; the trailing twelve-month figure through Mar 2026 stood at -$59.0 million (down 44.87% YoY), and the FY2025 full-year result was -$75.1 million, down 21.74% from the prior year.
- Profit After Tax climbed to -$624000.0 in Q1 2026, from -$20.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $929000.0 in Q3 2024 to a low of -$20.3 million in Q4 2025.
- A 3-year average of -$12.4 million and a median of -$16.5 million in 2025 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax tumbled 2257.27% in 2025 and surged 96.21% in 2026, its largest moves.
- Tracing SION's Profit After Tax over 3 years: stood at -$16.6 million in 2024, then decreased by 21.94% to -$20.3 million in 2025, then soared by 96.92% to -$624000.0 in 2026.
- Business Quant data shows SION's Profit After Tax at -$624000.0 in Q1 2026, -$20.3 million in Q4 2025, and -$20.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Sionna Therapeutics | 1.98 Bn | 1.98 Bn | - | -624,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -624,000.00 |
| Dec 31, 2025 | -20.27 Mn |
| Sep 30, 2025 | -20.04 Mn |
| Jun 30, 2025 | -18.07 Mn |
| Mar 31, 2025 | -16.48 Mn |
| Dec 31, 2024 | -16.62 Mn |
| Sep 30, 2024 | 929,000.00 |
| Jun 30, 2024 | -8.55 Mn |
| Mar 31, 2024 | -11.85 Mn |